Current Chlamydia Trachomatis Infection, A Major Cause of Infertility
Current Chlamydia Trachomatis Infection, A Major Cause of Infertility
Current Chlamydia Trachomatis Infection, A Major Cause of Infertility
1- Department of Health Research, Indian Council of Medical Research, National Institute for Research in Reproductive Health,
Mumbai, India
2- Seth G S Medical College and KEM Hospital, Parel, Mumbai, India
3- Seven Hills Hospital, Mumbai, India
Abstract
Background: In India, the impact of current Chlamydia trachomatis (C. tracho-
matis) in reproductive health remains a neglected area of investigation. The present
study evaluates if current Chlamydia infection is associated with any clinical com-
plication that needs the attention of clinical investigators.
Methods: In this cross-sectional study, we enrolled 896 women attending the Gyne-
cology Out Patient for the detection of C. trachomatis infection. Polymerase chain
reaction was used to diagnose current C. trachomatis infection and ELISA for past
infections. Bacterial vaginosis, Candida and Trichomonas were screened. The results
of symptomatic and asymptomatic groups were compared. The data was analyzed
using Epi Info version 6 and "Z" test. A probability value of p≤0.05 was considered
as significant.
Results: Statistical analysis revealed significant association between current C. tra-
chomatis infection with infertility when comparing infected fertile (18.6% vs. 9.4%,
* Corresponding Author:
Jayanti Mania-Pramanik, odds ratio: 2.19, p<0.0005) and uninfected infertile women (45.6% vs. 27.3%, odds
Infectious Diseases Biolo- ratio: 2.24, p<0.0001). Average infection rate was 12.1%, highest in women with in-
gy, National Institute for fertility (18.6%) or with ectopic pregnancy (25%). Significant proportions of infect-
Research in Reproductive ed women with infertility (p<0.01) or with recent pregnancy (p<0.001) were asymp-
Health, Indian Council of
Medical Research, De-
tomatic. Follow up of infected women who became negative after treatment [28
partment of Health Re- women from infertility group and 9 women with recurrent spontaneous abortion
search, Mumbai, India (RSA)] revealed live birth in 8 (21.6%) women within one year, 4 with infertility
E-mail: and 4 with RSA.
jayantimania@rediffmail. Conclusion: Study findings suggest association between current C. trachomatis in-
com
fection and infertility. Absence of signs and symptoms associated with this infection
Received: Jun. 23, 2012 highlights its diagnosis in women with a history of infertility and RSA for their bet-
Accepted: Jul. 7, 2012 ter management, as revealed by live births with one year of follow up.
Introduction
iagnosis, treatment and prevention of sexual- tions like mucopurulent endocervicites, endo-
ly transmitted Chlamydia infection has be- metritis or salpingitis have been attributed to this
come an important public health priority es- infection. The potentially serious sequelae of cer-
pecially, by strong evidence linking this infection vical infection with C. trachomatis includes infer-
with HIV transmission (1). Consequences of Chla- tility, ectopic pregnancy, pelvic pain and recurrent
mydia trachomatis (C. trachomatis) infection are pelvic inflammatory diseases (PID) (2−4). How-
more damaging to the reproductive health of ever, all the infected individuals do not develop
women than to men. A number of clinical condi- such complications or symptoms, as only a frac-
each), 0.2 mM dNTP’s, PCR buffer (10 mM Tris this product is directly proportional to the amount
buffer; pH=9), 1.25 units of Taq polymerase, 10 of Chlamydia-specific IgG antibodies in the spec-
μl of DNA specimen and the volume was adjusted imen. The specimens with O.D. higher than the
with sterile distilled water. Positive and negative cut-off value (0.250−0.900) were considered posi-
controls were also run in each experiment. Reac- tive for Chlamydia-specific antibodies and used as
tion was performed in a thermal cycler (Perkin an indicator of past Chlamydia infection. Each
Elmer 2400) as per the following protocol: initial positive sample was again confirmed using anoth-
denaturation was done for 5 min at 94 °C. This er serum aliquot of the same participant. The re-
was followed by 35 cycles of 30 s each of dena- sults were found to be reproducible.
turation at 94 °C, annealing at 55 °C and exten- Follow up of C. trachomatis positive cases: Coun-
sion at 72 °C for 1 min. The final extension step seled each enrolled women to come back to take
was carried out at 72 °C for 5 min. The amplified the report. Those found to be infected with any of
products were run on 2% Agarose gel, observed these infections were treated by the clinician.
under a UV transilluminator while the results Statistical analysis: Statistical analysis using Epi
were being documented. Presence of 180 bp re- Info version 6 software for Chi-squares (χ2) test
peat sequences in positive control specimen and was applied to study the association between C.
its absence in the negative control indicated reac- trachomatis infection with the clinical manifesta-
tion had been completed satisfactorily. Presence tions. The test of significance for proportion be-
of 180 bp repeat sequences in other clinical spec- tween different groups was carried out using "Z"
imens indicated presence of C. trachomatis infec- test. A probability value of p≤0.05 was considered
tion. Further confirmation of these amplified as significant.
products was carried out using specific C. tra-
chomatis probe in Southern hybridization (14). Results
Probe was prepared using PCR dig-labeling kit Study subjects: Eight hundred and ninety-six
(Roche diagnostics). Standard protocol for South- women were tested for current C. trachomatis
ern blotting was followed for transfer of PCR infection by PCR. The participants were between
products to a nylon membrane, which was then 16 to 45 years old with a median age of 29 yrs,
processed for hybridization using a generic probe. and an interquartile range (IQR) value of 10. They
Instruction manual was followed to detect the belonged to middle socio-economic groups and
probe complex using Dig-luminescence detection their personal history did not reveal any high risk
kit (Roche diagnostics). behavior. The number of women in asymptomatic
Detection of C. trachomatis IgG antibody: Com- control group, as well as those in groups with dif-
mercially available enzyme-linked immunosorb- ferent clinical histories like RSA, infertility, with
ent assay (ELISA) kit was used to detect C. tra- lower genital tract infection (LGTI), pregnant
chomatis specific IgG antibody (NovaTec Im- women from antenatal care (ANC) centers, their
munodiagnostica, GMBH). In brief, microtitre age and the infection rate in each group is pre-
wells precoated with C. trachomatis antigens were sented in table 1.
incubated with serum specimen at a 1:100 dilution In the RSA group, there were 58 women with 2
so that any corresponding antibodies present in pregnancy losses (2SA), 77 women with more
the serum would bind to the antigen to form com- than 3 pregnancy losses (>3SA) and 8 with ectop-
plexes. After washing the wells to remove all un- ic pregnancy. In the ANC group, the gestational
bound sample material, horseradish peroxidase period of the pregnant women varied from 2 to 4
(HRP) labeled anti-human IgG conjugate was months. There were 108 (12.1%) women with cur-
added which would bind to captured Chlamydia rent C. trachomatis, indicating the prevalence of
specific antibodies. The immune complex formed this infection in the study population.
by the bound conjugate was visualized by adding Presence of other reproductive tract infections and
tetramethylbenzidine (TMB) substrate, which past C. trachomatis infection: Of the 108 C. tracho-
gives a blue colored reaction product. matis infected women, 4 (3.7%) had concomitant
After terminating the reaction using a stop solu- BV while 1 (0.9%) had concomitant Candida
tion (Sulphuric acid, 0.2 mol/l), the absorbance of albicans. In the rest of participants (n=788), C.
the end product, which is yellow in color, was trachomatis specific antibody was present in 14
read at 450 nm using an ELISA plate reader (μ women, one woman had both the antibody and the
Quant, Bio-Tek Instruments Inc.). The intensity of antigen. Eighty women had other infections such
as BV, Candida or Trichomonas infections and the {9.4% (46 of 489); odds ratio: 2.19, p<0.0005)}
related infection rates were 14.5%, 4.3% and when compared to infected infertile women (18.6%,
0.9%, respectively. For further analysis, these 49 of 264). Comparison of clinical manifestation
women with C. trachomatis antibody (n=15), as of women with only current C. trachomatis infec-
well as those with other infections (n=80) were tion (n=103) with that of uninfected women
excluded. Hence, there were 693 women without (n=693) revealed significant association of C. tra-
any infection, who were taken into consideration chomatis infection with infertility (45.6% vs.
for comparative analysis (Table 2). 27.3%, p=0.0001; Table 2). Another significant
Sequelae, symptoms and signs associated with cur- observation was the absence of any symptoms or
rent C. trachomatis: Infection rate varied from signs on per speculum examination in infertile
1.96% to 25.0% among the different groups of (64% vs. 36%, p<0.01) and pregnant (79.2% vs.
participants (Table1). Among the RSA subgroup 22.8%, p≤0.001) infected women, indicating
a significant (p<0.001) proportion of women with asymptomatic nature of this infection (Figure 1).
ectopic pregnancy (25%) and with more than 2 Age associated with current C. trachomatis infec-
spontaneous abortions (10.4%) had this infection, tion: C. trachomatis infection was highest (21.8%)
compared to women with 2 spontaneous abortions among women 20 years old or younger, though
(5.2%). C. trachomatis infection rate was signifi- not statistically significant, and lowest in 21−25
cantly low in the group of women with children or year old age group. The infection rate again show-
expecting a child such as asymptomatic controls ed an increasing trend in women above 26−40
(n=102), LGTI (n=213) or in ANC (n=174) groups, years of age.
Table 2. Frequency of clinical manifestations with or without current C. trachomatis infection in women who did not have any other infec-
tion and their treatment outcome
C. trachomatis
Treatment outcome
Positive Negative
C. trachomatis
Treatment Live birth after Loss to
Women N=103 N=693 OR χ2 p
given treatment follow up
Negative Positive
N (%) (%)
Infertility 47 45.6 189 27.27 2.24 13.3 0.00014 42 28 2 4 12
RSA 11 10.7 106 15.29 0.66 1.63 0.217 11 9 2 4 -
not
ANC 24 23.3 138 19.91 1.22 4.47 0.425 8 8 -
known
LGTI 19 18.4 168 24.24 0.71 1.13 0.195 9 9 -- -- --
Asymptomatic control 2 1.9 92 13.28 - 9.67 0.0002 2 2 -- -- --
Total 103 - 693 -- -- -- -- 72 48 4 16 12
Notes: Infertility=Women unable to conceive after two years of cohabitation with husband; RSA=Recurrent spontaneous abortion; ANC=Antenatal cases or pregnant
women; LGTI=Lower genital tract infections; Asymptomatic controls=Healthy women without any sign or symptoms of any infection or disease
References 2006;20(1):8-14.
1. Grosskurth H, Mosha F, Todd J, Mwijarubi E, 15. Siemer J, Theile O, Larbi Y, Fasching PA, Danso
Klokke A, Senkoro K, et al. Impact of improved KA, Kreienberg R, et al. Chlamydia trachomatis
treatment of sexually transmitted diseases on HIV infection as a risk factor for infertility among
infection in rural Tanzania: randomised controlled women in Ghana, West Africa. Am J Trop Med
trial. Lancet. 1995;346(8974):530-6. Hyg. 2008;78(2):323-7.
2. Bébéar C, de Barbeyrac B. Genital Chlamydia tra- 16. Chandhok N, Datey S, Gaur LN, Saxena NC. Prev-
chomatis infections. Clin Microbiol Infect. 2009; 15 alence of chlamydia trachomatis in women attend-
(1):4-10. ing different clinics at tertiary hospitals. J Obstet
3. Darville T, Hiltke TJ. Pathogenesis of genital tract Gynecol India. 2003;53(5):463-7.
disease due to Chlamydia trachomatis. J Infect Dis. 17. Mania-Pramanik J, Meherji P, Gokral J, Donde U.
2010;201 Suppl 2:S114-25. Chlamydia trachomatis infection in an urban set-
4. Haggerty CL, Gottlieb SL, Taylor BD, Low N, Xu ting. Sex Transm Infect. 2001;77(2):141.
F, Ness RB. Risk of sequelae after Chlamydia tra- 18. Divekar AA, Gogate AS, Shivkar LK, Gogate S,
chomatis genital infection in women. J Infect Dis. Badhwar VR. Disease prevalence in women at-
2010;201 Suppl 2:S134-55. tending the STD clinic in Mumbai (formerly Bom-
bay), India. Int J STD AIDS. 2000;11(1):45-8.
5. Stamm WE. Chlamydia trachomatis infections of
the adult. In: Holmes KK, Sparling PF, Mardh PA, 19. Witkin SS, Ledger WJ. Antibodies to Chlamydia tra-
editors. Sexually transmitted diseases. New York: chomatis in sera of women with recurrent sponta-
McGraw-Hill; 1999. p. 407-22. neous abortions. Am J Obstet Gynecol. 1992;167
(1):135-9.
6. Schachter J, Stoner E, Moncada J. Screening for
chlamydial infections in women attending family 20. Schachter J. Infection and disease epidemiology.
planning clinics. West J Med. 1983;138(3):375-9. In: Stephens RS, editor. Chlamydia intracellular bi-
ology, pathogenesis, and immunity. Washington DC:
7. Cates W Jr, Wasserheit JN. Genital chlamydial in-
American Society for Microbiology; 1999. p. 139-69.
fections: epidemiology and reproductive sequelae.
Am J Obstet Gynecol. 1991;164(6 Pt 2):1771-81. 21. Thompson SE, Washington AE. Epidemiology of
sexually transmitted Chlamydia trachomatis infec-
8. Malik A, Jain S, Hakim S, Shukla I, Rizvi M.
tions. Epidemiol Rev. 1983;5:96-123.
Chlamydia trachomatis infection & female infertili-
ty. Indian J Med Res. 2006;123(6):770-5. 22. Sellors JW, Mahony JB, Chernesky MA, Rath DJ.
Tubal factor infertility: an association with prior
9. Mittal A, Kapur S, Gupta S. Screening for genital
chlamydial infection and asymptomatic salpingitis.
chlamydial infection in symptomatic women. Indi-
Fertil Steril. 1988;49(3):451-7.
an J Med Res. 1993;98:119-23.
23. Osser S, Persson K, Liedholm P. Tubal infertility
10. Singh V, Rastogi S, Garg S, Kapur S, Kumar A,
and silent chlamydial salpingitis. Hum Reprod.
Salhan S, et al. Polymerase chain reaction for detec-
1989;4(3):280-4.
tion of endocervical Chlamydia trachomatis infec-
tion in women attending a gynecology outpatient 24. Moscicki B, Shafer MA, Millstein SG, Irwin CE Jr,
department in India. Acta Cytol. 2002;46(3):540-4. Schachter J. The use and limitations of endocer-
vical Gram stains and mucopurulent cervicitis as
11. Nugent RP, Krohn MA, Hillier SL. Reliability of
predictors for Chlamydia trachomatis in female ad-
diagnosing bacterial vaginosis is improved by a
olescents. Am J Obstet Gynecol. 1987;157(1):65-71.
standardized method of gram stain interpretation. J
Clin Microbiol. 1991;29(2):297-301. 25. Eltabbakh GH, Eltabbakh GD, Broekhuizen FF,
Griner BT. Value of wet mount and cervical cul-
12. Lahiri DK, Nurnberger JI Jr. A rapid non-
tures at the time of cervical cytology in asympto-
enzymatic method for the preparation of HMW
matic women. Obstet Gynecol. 1995;85(4):499-
DNA from blood for RFLP studies. Nucleic Acids
503.
Res. 1991;19(19):5444.
26. Brabin L, Gogate A, Gogate S, Karande A, Khan-
13. Stephens RS, Mullenbach G, Sanchez-Pescador R,
na R, Dollimore N, et al. Reproductive tract infec-
Agabian N. Sequence analysis of the major outer
tions, gynaecological morbidity and HIV sero-
membrane protein gene from Chlamydia trachoma-
prevalence among women in Mumbai, India. Bull
tis serovar L2. J Bacteriol. 1986;168(3):1277-82.
World Health Organ. 1998;76(3):277-87.
14. Mania-Pramanik J, Potdar S, Kerkar S. Diagnosis of
Chlamydia trachomatis infection. J Clin Lab Anal.